Innospec INC Form 4 insider transactions

Corbin Barnes, SVP, Corporate Dev and IR of Innospec Inc., received 2,642 shares of common stock on October 1, 2026.

Hardy Louis Griffin Iii, SVP, HUMAN RESOURCES of Innospec Inc., received 2,685 shares of common stock on October 1, 2026.

Ian Cleminson, EVP & CFO of Innospec Inc., received 4,792 shares of common stock on October 1, 2026.

Ian Malcolm Mcrobbie, Senior VP R&T of Innospec Inc., received 3,164 shares of common stock on October 1, 2026.

David B. Jones, SVP, GC & CCO of Innospec Inc., received 3,188 shares of common stock on October 1, 2026.

Patrick Williams, PRESIDENT & CEO of Innospec Inc., received 22,203 shares of common stock on October 1, 2026.

INNOSPEC Director Milton C. Blackmore filed an amended Form 4 to correct reported sale prices for common stock transactions on February 27, 2026.

Innospec Director Larry Padfield filed an amended Form 4 to correct reported sale prices for common stock transactions on February 27, 2026.

Innospec Inc. Director Claudia Poccia filed an amended Form 4 to correct the reported transaction prices for two sales of common stock on February 27, 2026.

Innospec Director David Landless filed an amended Form 4 to correct previously reported stock sale prices from February 27, 2026.

INNOSPEC's EVP & CFO, Ian Cleminson, filed an amended Form 4 to correct previously reported stock sale prices from February 27, 2026.

Innospec Inc. Director Milton C. Blackmore reported the sale of 594 shares of common stock at $76.5562 per share.

Innospec Director Larry Padfield reported a planned sale of 594 shares of common stock on February 27, 2026, at $76.5562 per share under a Rule 10b5-1 plan.

INNOSPEC INC. Director Claudia Poccia sold 119 shares of common stock at $76.5562 per share to cover tax withholding obligations related to restricted stock unit vesting.

Innospec's SVP of Human Resources, Hardy Louis Griffin III, sold 401 shares of common stock to cover tax liabilities from a restricted stock unit award vesting.

INNOSPEC Director David Landless sold 594 shares of common stock at $76.5562 per share on February 27, 2026, under a Rule 10b5-1 plan.

Innospec's SVP, General Counsel, and Chief Compliance Officer, David B. Jones, reported the sale of company common stock following the vesting of restricted stock units.

Innospec Inc.'s SVP of Corporate Development and IR, Corbin Barnes, disposed of 166 shares of common stock to cover tax liabilities from a restricted stock unit vesting.

Innospec Inc.'s EVP & CFO, Ian Cleminson, sold 2,380 shares of common stock for $76.56 per share under a pre-arranged plan.

Innospec Inc.'s President and CEO, Patrick Williams, disposed of 7,966 shares of common stock to cover tax liabilities related to a restricted stock unit award vesting.

Innospec Inc. SVP Corbin Barnes received a grant of 2,481 Restricted Stock Units, vesting in 2029.

Innospec Inc.'s SVP of Human Resources, Hardy Louis Griffin III, was granted 2,521 Restricted Stock Units vesting in 2029.

Innospec Inc.'s EVP & CFO, Ian Cleminson, was granted 4,499 Restricted Stock Units, vesting in full on February 23, 2029.

Innospec Inc.'s President and CEO, Patrick Williams, was granted 20,846 Restricted Stock Units (RSUs) that will vest in 2029.

INNOSPEC INC. Senior Vice President, General Counsel & Chief Compliance Officer David B. Jones was granted 2,993 Restricted Stock Units.

Innospec Inc.'s Head of Group Finance, Graeme Blair, was awarded 520 phantom stock units, set to settle in cash in 2029.

Innospec's Senior VP of R&T, Ian Malcolm McRobbie, was awarded 2,228 shares of phantom stock, set to settle in cash in 2029.

INNOSPEC Director Elizabeth K. Arnold was granted 1,539 Restricted Stock Units as compensation for her service.

Innospec Inc. Director Leslie J. Parrette was granted 1,539 Restricted Stock Units, vesting in 2029, as compensation for her non-employee director service.

INNOSPEC Inc. Director David Landless was granted 1,539 Restricted Stock Units, vesting in 2029, as part of his non-employee director compensation.